keloid. Acne keloid
Conditions
Interventions
Intervention 1: Intervention group: Intralesional injection of vitamin D 300,000 units (manufactured by Caspian Pharmaceutical Co.) at a concentration of 0.2 per mL, with a maximum dose of 1 mL per le
Sponsors
Hamedan University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 60 Years
Inclusion criteria
Inclusion criteria: Age 18 to 60 years, Keloid lesion with a maximum size of 5 cm, less than 5 years old,
Exclusion criteria
Exclusion criteria: Pregnancy or breastfeeding, History of prior treatment within the last 3 to 4 months, Keloid lesion on the face, Active infection at the keloid lesion site.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Scar severity. Timepoint: Before the intervention and three months later. Method of measurement: Using the Vancouver Scar Scale (VSS).;Pain intensity. Timepoint: Before the intervention and three months later. Method of measurement: Using the Visual Analog Scale (VAS). | — |
Secondary
| Measure | Time frame |
|---|---|
| Local complications (burning sensation, pain, itching, inflammation). Timepoint: Three months after the intervention. Method of measurement: By taking a medical history and performing a clinical examination. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDr Seyyed Mohammad Noorolahi
Hamedan University of Medical Sciences
Outcome results
None listed